01.10.2014 | Commentary
Oral chemotherapy prescription safety practices in Europe
Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2014
Einloggen, um Zugang zu erhaltenExcerpt
-
Two recent surveys on oral chemotherapy from Spain and France provide novel data in a European setting on this field.
-
Depending on the country, oral chemotherapy can be dispensed by community pharmacists or by hospital pharmacists, with notable differences in their involvement in the safety practices.
-
It is valuable to have a hospital pharmacist with experienced in oncology to be directly involved in the education also when an oral antineoplastic agent is dispensed to minimize potential errors, improve patient outcomes and compliance.